Lung Cancer Clinical Trial
Official title:
A Randomized Prospective Study Comparing Annual Chest X-Rays to Annual Spiral Chest CT Scanning in Patients at High-Risk for the Development of Lung Cancer
RATIONALE: Diagnostic procedures such as chest x-ray and chest CT scans may be effective in
early detection of lung cancer.
PURPOSE: Randomized clinical trial to compare the effectiveness of a chest CT scan given
once a year with that of a chest x-ray given once a year in detecting lung cancer in
patients at a high-risk of developing lung cancer.
OBJECTIVES: I. Determine the efficacy of a lung cancer risk assessment questionnaire
combined with spirometry testing in identifying a statistically significant number of
persons with high-risk behaviors for the development of lung cancer. II. Determine the
sensitivity of these screening techniques in identifying a population at high risk for the
development of lung cancer. III. Determine the number of patients necessary to screen in
order to identify the high-risk population eligible for this study. IV. Determine the lead
time bias of CT scans versus chest x-rays in these patients. V. Determine the efficacy of
spiral CT scanning of the chest in detecting early lung cancers not visible on chest x-rays
in patients at high risk for lung cancer. VI. Compare annual spiral CT scanning versus
annual chest x-rays in detecting lung cancer in these patients. VII. Compare survival and
fatality in these patients with these detection methods.
OUTLINE: Patients are randomized to one of two screening arms. Arm I: Patients receive
routine medical care, an annual nursing assessment, and an annual chest x-ray. Any new
abnormality identified is further evaluated through standard acceptable medical
interventions. Arm II: Patients receive routine medical care, an annual nursing assessment,
and an annual spiral CT scan of the chest. If an abnormal mass greater than 10 mm in
diameter or 5-10 mm in diameter and highly suspicious for malignancy is detected, chest
x-ray and tissue diagnosis is obtained. If the abnormal mass is 10 mm or less in diameter, a
thin section high resolution image of the mass is obtained. If this image is normal or
benign, annual spiral CT scanning is continued. If the image is indeterminate, a repeat high
resolution scan is performed in 3 months. If the image is unchanged at 3 months, annual
spiral CT scanning is continued. If the mass is larger at 3 months, chest x-ray and tissue
diagnosis is performed. Screening continues for 5 years in the absence of disease detection.
PROJECTED ACCRUAL: A minimum of 1,000 patients (500 per screening arm) will be accrued for
this study.
;
Primary Purpose: Screening
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03918538 -
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
|
N/A | |
| Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
| Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
| Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
| Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
| Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
| Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
| Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
| Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
| Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
| Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
| Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
| Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
| Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
| Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|